BCIQ Profiles

Company Profile ReportTarget Profile Report

Stapled peptide company FOG raises $66M series B

FOG Pharmaceuticals Inc. (Cambridge, Mass.) raised $66 million in a series B round led by 6 Dimensions Capital. New investors GV, Blue Pool Capital, Horizons Ventures, Nan

Read the full 277 word article

How to gain access

Continue reading with a
two-week free trial.